Lopinavir
C37H48N4O5
628.80
[1S-[1R*(R*),3R*,4R*]]-N-[4[[(2,6-Dimethylphenoxy) acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide;
(αS)-Tetrahydro-N-[(αS)-α-[(2S,3S)-2-hydroxy-4-phenyl-3-[2-(2,6-xylyloxy)acetamido]butyl]phenethyl]-α-isopropyl-2-oxo-1(2H)-pyrimidineacetamide [192725-17-0]
[1S-[1R*(R*),3R*,4R*]]-N-[4[[(2,6-Dimethylphenoxy) acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide;
(αS)-Tetrahydro-N-[(αS)-α-[(2S,3S)-2-hydroxy-4-phenyl-3-[2-(2,6-xylyloxy)acetamido]butyl]phenethyl]-α-isopropyl-2-oxo-1(2H)-pyrimidineacetamide [192725-17-0]
DEFINITION
Lopinavir contains NLT 98.0% and NMT 102.0% of lopinavir (C37H48N4O5), calculated on the anhydrous basis.